Baggen, M.G.A.

patient albumin excretion rate losartan type 2 diabetes diabetes blood pressure blood albumin excretion study placebo pressure group microalbuminuria normotensive patients effect normotensive treatment placebo group 5 weeks reduction albumin excretion creatinine clearance mellitu 100 mg hypertensive patients baseline antagonist hypertensive creatinine change hospital antiproteinuric trial losartan group 50 mg clearance nephropathy placebo groups antiproteinuric effects level antiproteinuric effect analysis 10 weeks angiotensin-receptor antagonists zeeuw end points haemolytic anaemia zandbergen protein irbesartan inhibitor haemolysi disease angiotensin-receptor mmol /l number baggen article period ikazia hospital medicine flow cytometry ouwendijk difference kidney 200 g /min netherland anaemia point 150/90 mm hg baseline blood pressures 140/90 mm hg event nephrol dial transplant ann intern med week 10 parving hh kidney int hypertension